Moderna’s coronavirus vaccine is very efficient, closing evaluation exhibits

0
54



Moderna’s coronavirus vaccine is 94.1% efficient in stopping COVID-19 and 100% efficient in stopping extreme sickness, in response to closing outcomes introduced by the corporate on Monday (Nov. 30).

Moderna can also be planning to file for an emergency use authorization (EUA) from the Meals and Drug Administration (FDA) on Monday. 

LEAVE A REPLY

Please enter your comment!
Please enter your name here